Myriad Genetics, Inc. (MYGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:07AM EDT. Market open.
| Previous close | 19.97 |
| Open | 19.96 |
| Bid | 19.56 x 200 |
| Ask | 19.69 x 100 |
| Day's range | 19.50 - 20.15 |
| 52-week range | 13.82 - 24.21 |
| Volume | |
| Avg. volume | 658,383 |
| Market cap | 1.776B |
| Beta (5Y monthly) | 1.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Myriad Genetics (NASDAQ:MYGN) shareholders have endured a 26% loss from investing in the stock five years ago
Ideally, your overall portfolio should beat the market average. But in any portfolio, there will be mixed results...
- Zacks
Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
Myriad (MYGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Myriad Genetics (MYGN) Announces Favorable Research Results
Myriad Genetics' (MYGN) latest positive initial study outcome is likely to improve clinical outcomes and reduce overall healthcare costs.
© 2024 Yahoo. All rights reserved.